56 Min.
New Hope For a new modified CAR T Therapy For Multiple Myeloma and other fatal hematologic malignancies Facing the Cancer Revolution
-
- Medizin
In this episode of Facing the Cancer Revolution Podcast we discuss Multiple myeloma cancer and new CAR-T Treatments for bone marrow cancers.
Multiple myeloma is a type of blood cancer that affects plasma cells, which are a type of white blood cells that produce antibodies to help fight infections. Treatment options for multiple myeloma have improved significantly in recent years with the introduction of new drugs and therapies.
Immunomodulatory Drugs (IMiDs): boost the immune system and target cancer cells. .
Proteasome inhibitors: Proteasomes are enzymes that break down proteins in cells, including those that cause cancer cells to grow.
Monoclonal antibodies: These are drugs that target specific proteins on the surface of cancer cells. .
CAR T-cell therapy: This is a type of immunotherapy where T cells (a type of immune cell) are modified in a laboratory to produce chimeric antigen receptors (CARs) that recognize and attack cancer cells.
High-dose chemotherapy and stem cell transplant: This treatment involves high-dose chemotherapy to kill cancer cells followed by a stem cell transplant to replace the damaged cells.
Targeted therapy: This is a type of treatment that targets specific molecules or genes that are involved in the growth and survival of cancer cells. .
Resources Discussed in Podcast
https://www.dana-farber.org/cellular-therapies-program/car-t-cell-therapy/car-t-cell-therapy-for-multiple-myeloma/
https://www.mayoclinic.org/diseases-conditions/multiple-myeloma/symptoms-causes/syc-20353378
https://stemcellthailand.org/oncology/multiple-myeloma-treatment/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439649/
https://www.mdanderson.org/cancerwise/car-t-cell-therapy-puts-smoldering-and-multiple-myeloma-survivor-in-remission.h00-159543690.html
Links to Previous Shows
Cancer immunotherapy: from T cell basics
Next generation of cancer treatments
Advanced liver cancer
Management of Liver Cancer
Biomarker-driven therapies for lung cancer
Understanding Carcinogenesis
Prostate Cancer
Pancreatic Cancer
In this episode of Facing the Cancer Revolution Podcast we discuss Multiple myeloma cancer and new CAR-T Treatments for bone marrow cancers.
Multiple myeloma is a type of blood cancer that affects plasma cells, which are a type of white blood cells that produce antibodies to help fight infections. Treatment options for multiple myeloma have improved significantly in recent years with the introduction of new drugs and therapies.
Immunomodulatory Drugs (IMiDs): boost the immune system and target cancer cells. .
Proteasome inhibitors: Proteasomes are enzymes that break down proteins in cells, including those that cause cancer cells to grow.
Monoclonal antibodies: These are drugs that target specific proteins on the surface of cancer cells. .
CAR T-cell therapy: This is a type of immunotherapy where T cells (a type of immune cell) are modified in a laboratory to produce chimeric antigen receptors (CARs) that recognize and attack cancer cells.
High-dose chemotherapy and stem cell transplant: This treatment involves high-dose chemotherapy to kill cancer cells followed by a stem cell transplant to replace the damaged cells.
Targeted therapy: This is a type of treatment that targets specific molecules or genes that are involved in the growth and survival of cancer cells. .
Resources Discussed in Podcast
https://www.dana-farber.org/cellular-therapies-program/car-t-cell-therapy/car-t-cell-therapy-for-multiple-myeloma/
https://www.mayoclinic.org/diseases-conditions/multiple-myeloma/symptoms-causes/syc-20353378
https://stemcellthailand.org/oncology/multiple-myeloma-treatment/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439649/
https://www.mdanderson.org/cancerwise/car-t-cell-therapy-puts-smoldering-and-multiple-myeloma-survivor-in-remission.h00-159543690.html
Links to Previous Shows
Cancer immunotherapy: from T cell basics
Next generation of cancer treatments
Advanced liver cancer
Management of Liver Cancer
Biomarker-driven therapies for lung cancer
Understanding Carcinogenesis
Prostate Cancer
Pancreatic Cancer
56 Min.